Face Shields in Pre-hospital Settings: Clinical Effectiveness and Guidelines Product: — Canadian Agency for Drugs and Technologies in Health Face Protection PPE covid.cadth.ca Last Updated: August 17, 2020 Also available in Français
Ongoing Trials for Bacille Calmette-Guérin (BCG) Vaccines in the Prevention of COVID-19 Product: — Canadian Agency for Drugs and Technologies in Health Vaccine Vaccines & Immunity covid.cadth.ca Last Updated: August 10, 2020 Also available in Français
Ongoing Trials for Novel Vaccines in the Prevention of COVID-19 Product: — Canadian Agency for Drugs and Technologies in Health Vaccine Vaccines & Immunity covid.cadth.ca Last Updated: August 10, 2020 Also available in Français
Needleless Injectors for the Administration of Vaccines: A Review of Clinical Effectiveness Product: — Canadian Agency for Drugs and Technologies in Health Vaccine Vaccines & Immunity covid.cadth.ca Last Updated: July 17, 2020 Also available in Français
COVID-19 Testing – Evidence and Best Practices Product: — Evidence Synthesis Network Serological Testing Signs & Symptoms Testing & Tracing esnetwork.ca Last Updated: June 25, 2020
Influenza Vaccination and Risk of Subsequent Non-Influenza Respiratory Viruses: Safety Product: — Canadian Agency for Drugs and Technologies in Health Vaccine Vaccines & Immunity covid.cadth.ca Last Updated: June 8, 2020 Also available in Français
Incremental Benefit of Using a History of Sudden Loss of Taste (Ageusia) And/Or Smell (Anosmia) in Symptom Screening for COVID-19 Product: — Evidence Synthesis Network Less Common Signs & Symptoms Signs & Symptoms Testing & Tracing Tracing esnetwork.ca Last Updated: May 28, 2020
Barriers Vulnerable Populations Face Regarding Adherence to COVID‑19 Public Health Measures Product: — Evidence Synthesis Network Barriers to Access Health Inequities Vulnerable Groups esnetwork.ca Last Updated: May 24, 2020